Sarah Boyce is the founder of Avidity Biosciences. Avidity Biosciences has raised $30M in total funding. Latest round: IPO.
Sarah Boyce is a life sciences executive who served as President & CEO of Avidity Biosciences, where she led the company through a significant transformation from Series C financing to an IPO. She also oversaw a historic scientific milestone involving targeted RNA delivery into human muscle.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide